Traders Are Watching: Energy XXI Ltd (NASDAQ:EXXI), Baltic Trading Limited (NYSE:BALT), Barnes & Noble, Inc. (NYSE:BKS), Alnylam Pharmaceuticals (NASDAQ:ALNY), OSI Systems (NASDAQ:OSIS)

Energy XXI Ltd (NASDAQ:EXXI) belongs to Basic Materials sector. Its net profit margin is -73.40% and weekly performance is -3.90%. On last trading day company shares ended up $2.22. Energy XXI Ltd (NASDAQ:EXXI) distance from 50-day simple moving average (SMA50) is -33.78%. On 1st July, Energy XXI Ltd (NASDAQ:EXXI) announced it has closed on the sale of the East Bay Field for $21 million to a private buyer. In addition, Energy XXI will retain a 5% overriding royalty interest on these assets for a period not to exceed 5 years from the closing date, and Energy XXI will also retain 50 percent of the deep rights associated with the East Bay Field.

Baltic Trading Limited (NYSE:BALT) shares advanced 4.14% in last trading session and ended the day at $1.51. BALT Gross Margin is 31.80% and its return on assets is -11.40%. Baltic Trading Limited (NYSE:BALT) quarterly performance is 5.59%. Zacks upgraded shares of Baltic Trading (NYSE:BALT) from a sell rating to a hold rating in a report released on Saturday.

On 10 July, Barnes & Noble, Inc. (NYSE:BKS) shares increased 0.22% and was closed at $26.81. BKS EPS growth in last 5 year was -19.70%. Barnes & Noble, Inc. (NYSE:BKS) year to date (YTD) performance is 15.46%. Barnes & Noble Inc. (NYSE:BKS) which plans to split into two companies next month, has tapped Sears Canada CEO Ronald Boire to lead the bookseller’s retail business. After the split, current CEO Michael Huseby will become executive chairman of the separate college bookstore business.

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) ended the last trading day at $121.77. Company weekly volatility is calculated as 4.37% and price to cash ratio as 9.62. Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) showed a weekly performance of 3.34%. Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), announced that it plans to host and webcast its annual summer series of online “RNAi Roundtables” on ALN-AT3 for the treatment of Hemophilia and Rare Bleeding Disorders on Wednesday, July 22, 9:00 – 10:30 a.m. ET.

OSI Systems, Inc. (NASDAQ:OSIS) shares advanced 2.34% in last trading session and ended the day at $71.42. OSIS Gross Margin is 33.80% and its return on assets is 6.30%. OSI Systems, Inc. (NASDAQ:OSIS) quarterly performance is -3.81%. On 30 June, OSI Systems, Inc., (NASDAQ:OSIS) has announced that its Healthcare division, Spacelabs Healthcare, has received an approximate $5 million order to provide patient monitoring solutions and related accessories to a prominent U.S. hospital.

Leave a Reply

Your email address will not be published. Required fields are marked *